TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31352800

Group type: EXPERIMENTAL
Intervention: Statin group (40 mg atorvastatin daily for 7 days before operation)
Number of subjects: 160
Study: 28716014

Group type: EXPERIMENTAL
Intervention: COMPASS care model
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6000
Study: 25666010

Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: White mineral trioxide aggregate (MTA)
Number of subjects: 37
Study: 25261291

Group type: EXPERIMENTAL
Intervention: lipegfilgrastim 6.0 mg
Number of subjects: 208

Group type: COMPARATOR
Intervention: pegfilgrastim 6.0 mg
Number of subjects: 208
Study: 22811596

Group type: EXPERIMENTAL
Intervention: Fluvastatin ER tablet 80 mg QD
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fluvastatin IR capsule 40 mg BID
Number of subjects: 20
Study: 19238124

Group type: EXPERIMENTAL
Intervention: Aripiprazole 15-30 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol 10-15 mg/day
Number of subjects: 0
Study: 17475739

Group type: EXPERIMENTAL
Intervention: Stepped treatment initiated with buprenorphine/naloxone
Number of subjects: 96

Group type: COMPARATOR
Intervention: Methadone maintenance therapy
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Stepped treatment and Methadone maintenance therapy
Number of subjects: 96
Study: 15022801

Group type: EXPERIMENTAL
Intervention: Immediate weight-bearing (I)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Late weight-bearing (L)
Number of subjects: 20
Study: 12500987

Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg.kg(‐1) before exercise and 0.33 mg.kg(‐1) every 15 min during exercise)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Carbohydrate (Cho)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Caffeine (Caf)
Number of subjects: 8
Study: 9536227

Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (50 micrograms/g) applied twice daily
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo (vehicle only) applied twice daily
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (50 micrograms/g) with acitretin
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Acitretin therapy
Number of subjects: 135
Study: 2051728

Group type: EXPERIMENTAL
Intervention: Different combinations of dialysate and substitution fluids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactate containing substitution fluid
Number of subjects: 0
Study: 6420609

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 at 3.3 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 at 12.5 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 at 50 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 at 100 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 at 200 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 (all dosages except 3.3 micrograms)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 (200 micrograms)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 (3.3 to 50 micrograms)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: hpGRF1-44 (up to 200 micrograms)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30678197

Group type: EXPERIMENTAL
Intervention: Telenutrition weight loss intervention with weekly support from a registered dietitian nutritionist via telephone and videoconferencing
Number of subjects: 59

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 59
Study: 28367771

Group type: EXPERIMENTAL
Intervention: Step stool use
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Adjusted height
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Visual feedback
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: JIT CPR training
Number of subjects: 124
Study: 26762723

Group type: EXPERIMENTAL
Intervention: CCTA-guided decision making (R-II)
Number of subjects: 647

Group type: COMPARATOR
Intervention: Standard care (R-I)
Number of subjects: 647
Study: 24594505

Group type: EXPERIMENTAL
Intervention: Lutein (21 mg capsules with 250 mL of full-cream milk per day for 4 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo (with 250 mL of full-cream milk per day for 4 weeks)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Lutein
Number of subjects: 44
Study: 22510023

Group type: EXPERIMENTAL
Intervention: Combination of HbA(1c) 39-46 mmol/mol (5.7-6.4%) and fasting plasma glucose 5.6-6.9 mmol/l
Number of subjects: 6241

Group type: EXPERIMENTAL
Intervention: Pre-diabetic individuals fulfilling HbA(1c) 42-46 mmol/mol (6.0-6.4%) and fasting plasma glucose 6.1-6.9 mmol/l
Number of subjects: 6241

Group type: EXPERIMENTAL
Intervention: Any of the four combined criteria for pre-diabetes
Number of subjects: 6241
Study: 20199960

Group type: EXPERIMENTAL
Intervention: Home fecal immunochemical test (FIT) for CRCS provided on 17 dates.
Number of subjects: 133

Group type: COMPARATOR
Intervention: CRCS education and encouragement to obtain screening from primary care clinician provided on 5 dates.
Number of subjects: 133
Study: 18207280

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) plus emtricitabine (FTC) combination therapy (n=14)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Adefovir dipivoxil (ADV) plus placebo monotherapy (n=16)
Number of subjects: 30
Study: 15871887

Group type: EXPERIMENTAL
Intervention: Functional Incidental Training (FIT)
Number of subjects: 64
Study: 12834321

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10770466

Group type: EXPERIMENTAL
Intervention: High-dose haloperidol with dose reduction to achieve target plasma level of 10 ng/mL over 12 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group maintained original high-dose haloperidol treatment
Number of subjects: 23
Study: 9310019

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid treatment, budesonide 400 micrograms twice daily
Number of subjects: 61

Group type: COMPARATOR
Intervention: Chronic asthma
Number of subjects: 61

Group type: COMPARATOR
Intervention: Seasonal asthma
Number of subjects: 61
Study: 8167083

Group type: EXPERIMENTAL
Intervention: Nitrous oxide in the anesthetic mixture
Number of subjects: 44

Group type: COMPARATOR
Intervention: No nitrous oxide in the anesthetic mixture
Number of subjects: 44
Study: 2944432

Group type: EXPERIMENTAL
Intervention: Nitrous oxide anaesthesia (Group A)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (Group B, no nitrous oxide)
Number of subjects: 87
Study: 31669136

Group type: EXPERIMENTAL
Intervention: Bolus injection of GIP (50 pmol/kg body weight at 30 and 120 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous infusion of GIP (2 pmol.kg-1.min-1 from 30 to 180 min)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bolus administration of GIP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous administration of GIP
Number of subjects: 0
Study: 30545134

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (3000 IU/day)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no vitamin D3 supplementation)
Number of subjects: 36
Study: 27039386

Group type: EXPERIMENTAL
Intervention: E7820 50 mg BID
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: E7820 60 mg BID
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: E7820 100 mg QD
Number of subjects: 41
Study: 25208796

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) therapy, 15 minutes, 3 times per week for 7 months
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Jumping Intervention (JIN), 3 times per week for 8 months
Number of subjects: 104

Group type: COMPARATOR
Intervention: Normal swimming training (control group)
Number of subjects: 104
Study: 22719814

Group type: EXPERIMENTAL
Intervention: BPN/NLX
Number of subjects: 94

Group type: COMPARATOR
Intervention: Non-BPN/NLX
Number of subjects: 94
Study: 20047610

Group type: EXPERIMENTAL
Intervention: Early reduction of corticosteroid dose (prednisone 5 mg every other day for 12 months)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Regular-dose corticosteroid maintenance (prednisone progressively reduced from days 8 to 90, then maintained for 12 months)
Number of subjects: 83
Study: 18692612

Group type: EXPERIMENTAL
Intervention: Regimen 1A (Dienogest dosage not specified)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Regimen 2A (Dienogest dosage not specified)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Regimen 2B (Increased Dienogest dosage)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Regimen 2C (Increased Dienogest dosage)
Number of subjects: 395
Study: 15721696

Group type: EXPERIMENTAL
Intervention: Myopic LASIK
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Hyperopic LASIK
Number of subjects: 54
Study: 11936481

Group type: EXPERIMENTAL
Intervention: Subcutaneous interferon beta-1a (IFNbeta-1a)
Number of subjects: 533
Study: 10528291

Group type: EXPERIMENTAL
Intervention: 5 min acquisition time for scintimammography
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 min acquisition time for scintimammography
Number of subjects: 0
Study: 7860310

Group type: EXPERIMENTAL
Intervention: Exposed group (cumulative radiation doses of about 500 mSv or more)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Unexposed group (cumulative radiation doses less than 50 mSv)
Number of subjects: 36
Study: 1816543

Group type: EXPERIMENTAL
Intervention: Dentin adhesives
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Adhesive formulated with glycidyl methacrylate
Number of subjects: 2

Group type: COMPARATOR
Intervention: Composite restorative materials without adhesives
Number of subjects: 2
Study: 7051507

Group type: EXPERIMENTAL
Intervention: Cinoxacin, 250 mg, qid for 7-14 days
Number of subjects: 95

Group type: COMPARATOR
Intervention: Nalidixic acid, 1 Gm, qid for 7-14 days
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Cinoxacin
Number of subjects: 95

Group type: COMPARATOR
Intervention: Nalidixic acid
Number of subjects: 95
Study: 31056655

Group type: EXPERIMENTAL
Intervention: Flavonoid-rich natural cocoa (F)
Number of subjects: 134
Study: 28418028

Group type: EXPERIMENTAL
Intervention: New algorithm for predicting advanced proximal neoplasia (APN) based on distal colonoscopic findings.
Number of subjects: 3889

Group type: COMPARATOR
Intervention: High Risk (HR) group based on a cut-off score of 2.
Number of subjects: 3889

Group type: EXPERIMENTAL
Intervention: Follow-up colonoscopies required to detect APN.
Number of subjects: 3889
Study: 27238963

Group type: EXPERIMENTAL
Intervention: Fulranumab 3mg every 4 weeks
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Fulranumab 9mg every 4 weeks
Number of subjects: 300

Group type: COMPARATOR
Intervention: Oxycodone CR twice-daily
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study: 23674935

Group type: EXPERIMENTAL
Intervention: Armodafinil (150 mg/day)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: CPAP treatment after 6 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Armodafinil vs Placebo
Number of subjects: 69
Study: 22320027

Group type: EXPERIMENTAL
Intervention: Dextromethorphan and quinidine (DMQ) at doses of 0, 30, and 60 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (0 mg DMQ)
Number of subjects: 9
Study: 18694599

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 83
Study: 17696825

Group type: EXPERIMENTAL
Intervention: APC8015 (Provenge®), an immunotherapeutic consisting of autologous dendritic cells pulsed ex vivo with PA2024.
Number of subjects: 0
Study: 15459950

Group type: EXPERIMENTAL
Intervention: Adhesive tablets with natural active agents
Number of subjects: 248

Group type: COMPARATOR
Intervention: Plain tablets (control)
Number of subjects: 248
Study: 11331049

Group type: EXPERIMENTAL
Intervention: Realtime teledermatology consultation
Number of subjects: 274

Group type: COMPARATOR
Intervention: Conventional hospital outpatient consultation
Number of subjects: 274

Group type: COMPARATOR
Intervention: Sensitivity analysis in urban areas
Number of subjects: 274

Group type: COMPARATOR
Intervention: Sensitivity analysis in rural areas
Number of subjects: 274
Study: 9571269

Group type: EXPERIMENTAL
Intervention: DAILIES(TM) daily disposable soft lenses for 8 hours
Number of subjects: 20
Study: 8027750

Group type: EXPERIMENTAL
Intervention: Doppler-guided needle device
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (standard technique)
Number of subjects: 41
Study: 2644752

Group type: EXPERIMENTAL
Intervention: Heparin (3 mg/kg bolus injection)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study: 31783936

Group type: EXPERIMENTAL
Intervention: Structured lifestyle intervention including motivational text messages for 8 weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Structured lifestyle intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 21
Study: 30900413

Group type: EXPERIMENTAL
Intervention: Bariatric Surgery
Number of subjects: 196

Group type: COMPARATOR
Intervention: Intensive Lifestyle Intervention (ILI)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Diabetes Support and Education (DSE)
Number of subjects: 196
Study: 27815700

Group type: EXPERIMENTAL
Intervention: Venoplant (diosmin, coumarin glycosides, and Centella asiatica) for 30 days post-SA
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo for 30 days post-SA
Number of subjects: 182
Study: 26658275

Group type: EXPERIMENTAL
Intervention: Individualized feedback regarding naturalistic driving record and CPAP compliance
Number of subjects: 66

Group type: COMPARATOR
Intervention: No feedback (control group)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Individualized feedback
Number of subjects: 66
Study: 23398927

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Text (TX)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Audio (AU)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Video (VD)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Technological breakdowns in VR
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Presence experience (SUS scores)
Number of subjects: 39
Study: 21442218

Group type: EXPERIMENTAL
Intervention: Timing cue present throughout the trial
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Timing cue present with directional cue
Number of subjects: 0

Group type: COMPARATOR
Intervention: Directional cue without timing cue
Number of subjects: 0
Study: 18171629

Group type: EXPERIMENTAL
Intervention: Brachial-basilic AVF (BB-AVF)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Prosthetic forearm loop AVF
Number of subjects: 61
Study: 16813738

Group type: EXPERIMENTAL
Intervention: Insulin-sensitizing treatment strategies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insulin-providing treatment strategies
Number of subjects: 0
Study: 14517164

Group type: EXPERIMENTAL
Intervention: Eplerenone 200 mg daily
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Enalapril 40 mg daily
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Eplerenone 200 mg and Enalapril 10 mg daily
Number of subjects: 202

Group type: COMPARATOR
Intervention: Eplerenone
Number of subjects: 202

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 202

Group type: COMPARATOR
Intervention: Eplerenone/Enalapril
Number of subjects: 202
Study: 10996360

Group type: EXPERIMENTAL
Intervention: Absence of the EcoRI restriction site (L4154) of the apo B gene
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: LPL S447stop mutation
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: LPL N291S mutation
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: S291 allele
Number of subjects: 214

Group type: COMPARATOR
Intervention: apo E and CETP genotypes
Number of subjects: 214
Study: 8869672

Group type: EXPERIMENTAL
Intervention: Pancuronium 0.1 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pipecuronium 0.1 mg/kg
Number of subjects: 20
Study: 1642124

Group type: EXPERIMENTAL
Intervention: Bright dawn simulation (1700 lx) from 0400 to 0600
Number of subjects: 7

Group type: COMPARATOR
Intervention: Standard bright morning light therapy (1700 lx) from 0600 to 0800
Number of subjects: 7
Study: 7198288

Group type: EXPERIMENTAL
Intervention: Restrictive treatment (bed rest in febrile stage, avoiding activities that promote headache)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Liberal treatment (encouraged to resume daily life as soon as possible)
Number of subjects: 39
Study: 29923314

Group type: EXPERIMENTAL
Intervention: RPR 102681 (cholecystokinin-B antagonist)
Number of subjects: 16
Study: 27664969

Group type: EXPERIMENTAL
Intervention: internet-based reporting group
Number of subjects: 40

Group type: COMPARATOR
Intervention: standard-of-care group
Number of subjects: 40
Study: 26335229

Group type: EXPERIMENTAL
Intervention: Video conferencing
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cellular communication
Number of subjects: 50
Study: 23694919

Group type: EXPERIMENTAL
Intervention: Adenosine stress thallium-201 myocardial perfusion imaging
Number of subjects: 41

Group type: COMPARATOR
Intervention: Exercise stress thallium-201 myocardial perfusion imaging
Number of subjects: 41
Study: 21444145

Group type: EXPERIMENTAL
Intervention: Instructor-led (IL) training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Self-learning (SL) station training
Number of subjects: 120
Study: 19546404

Group type: EXPERIMENTAL
Intervention: Vaginal brachytherapy (VBT)
Number of subjects: 427

Group type: COMPARATOR
Intervention: External-beam radiotherapy (EBRT)
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 427
Study: 17298579

Group type: EXPERIMENTAL
Intervention: Red cell volume-based guideline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haemoglobin-based protocol
Number of subjects: 0
Study: 15323600

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 199

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study: 11584088

Group type: EXPERIMENTAL
Intervention: Weekly vitamin A and iron supplementation (4800 retinol equivalents (RE) + 120 mg Fe as FeSO(4) + 500 microg folic acid)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Weekly iron supplementation (120 mg Fe as FeSO(4) + 500 microg folic acid)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Weekly vitamin A and iron supplementation
Number of subjects: 170

Group type: COMPARATOR
Intervention: Weekly iron supplementation
Number of subjects: 170
Study: 9564665

Group type: EXPERIMENTAL
Intervention: GnRH-agonist therapy for three months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative treatment for three months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical approaches (laparoscopy or minilaparoscopy)
Number of subjects: 0
Study: 7868106

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 2671402

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (HSL, Na 250 mEq/L, 514 mOsm)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Lactated Ringer's solution (LR, Na 130 mEq/L, 268 mOsm)
Number of subjects: 51
Study: 618025

Group type: EXPERIMENTAL
Intervention: Low concentrations of noxious gases from machinery and explosives
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Standard questionnaire (E.C.S.C. bronchitis/emphysema questionnaire) and clinical examination
Number of subjects: 1178

Group type: EXPERIMENTAL
Intervention: Venous blood sample for blood CO determination
Number of subjects: 1178
Study: 31796986

Group type: EXPERIMENTAL
Intervention: Tocilizumab (IL-6 receptor antagonist) 8 mg/kg every 4 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Sitagliptin (DPP-4 inhibitor) 100 mg daily
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (saline infusion every 4 weeks and placebo pill once daily)
Number of subjects: 52
Study: 31174168

Group type: EXPERIMENTAL
Intervention: Nicotine e-cigarette
Number of subjects: 128

Group type: COMPARATOR
Intervention: Non-nicotine e-cigarette with instructions indicating nicotine
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Nicotine e-cigarette with complementary instructions
Number of subjects: 128
Study: 27079636

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (1×10^9 CFU containing seven strains of lactic acid-producing bacteria) every 12 hours for six weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (identical capsule)
Number of subjects: 65
Study: 25727879

Group type: EXPERIMENTAL
Intervention: HeartNetCare-HF (HNC)
Number of subjects: 706
Study: 23812094

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg per day
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study: 21785368

Group type: EXPERIMENTAL
Intervention: Web-based health and leadership development program
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 145
Study: 19031167

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo Laser
Number of subjects: 67
Study: 17697065

Group type: EXPERIMENTAL
Intervention: Insulin aspart (0.1 u/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Regular insulin (0.1 u/kg)
Number of subjects: 19
Study: 15318285

Group type: EXPERIMENTAL
Intervention: Cyriax approach (CYR) - deep friction massage and mobilisation exercises three times weekly
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physical therapy (PT) - daily physical therapy including hot pack and short wave diathermy application
Number of subjects: 40
Study: 12441023

Group type: EXPERIMENTAL
Intervention: Serotonergic antidepressants (first-line treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs) during symptomatic luteal phase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow-release formulation of fluoxetine (taken two times during the menstrual cycle)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral contraceptives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New contraceptive formulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Progesterone and progestins
Number of subjects: 0